Literature DB >> 22695711

Nutrition and the open abdomen.

Nathan J Powell1, Bryan Collier.   

Abstract

Adequate nutrition support is critical in the management of patients with an open abdomen. Despite the literature supporting its use in trauma patients, provider concerns and clinical controversies remain regarding the early administration and long-term sequelae of enteral nutrition (EN) therapy in these patients. The purpose of this article is to review the clinical concepts behind the use of the open abdomen, as well as examine the altered nutrition requirements associated with the maintenance of a temporary laparostomy. The rationale for early EN is described, as well as the pros and cons surrounding the use of supplemental parenteral nutrition in those patients unable to meet nutrition goals enterally in a reasonable time frame. Finally, an open abdomen nutrition support algorithm is provided as part of the critical care plan in these patients who represent the sickest of surgical patients.

Entities:  

Mesh:

Year:  2012        PMID: 22695711     DOI: 10.1177/0884533612450918

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  3 in total

1.  VAWCM-Instillation Improves Delayed Primary Fascial Closure of Open Septic Abdomen.

Authors:  Qingsong Tao; Jianan Ren; Zhenling Ji; Shengli Liu; Baochai Wang; Yu Zheng; Guosheng Gu; Xinbo Wang; Jieshou Li
Journal:  Gastroenterol Res Pract       Date:  2014-12-07       Impact factor: 2.260

2.  Successful Negative Pressure Therapy of Enteroatmospheric Fistula after Right Colectomy for Complicated Crohn's Disease -A Proposal for a Three-Drain Wound-Separation Technique.

Authors:  Georgi Popivanov; Roberto Cirocchi; Dimitar Penchev; Kirien Kjossev; Marina Konaktchieva; Ventsislav Mutafchiyski
Journal:  Medicina (Kaunas)       Date:  2022-01-28       Impact factor: 2.430

Review 3.  Current status of the open abdomen treatment for intra-abdominal infection.

Authors:  Yujie Yuan; Jianan Ren; Yulong He
Journal:  Gastroenterol Res Pract       Date:  2013-10-02       Impact factor: 2.260

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.